TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Narcotic (Opioid) Drugs Market Insights, Forecast to 2028

Global Narcotic (Opioid) Drugs Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 04 July 2022
  • Pages :111
  • Formats:
  • Report Code:SMR-7179027
OfferClick for best price

Best Price: $3920

Narcotic Opioid Drugs Market Size, Share 2022


Market Analysis and Insights: Global Narcotic Opioid Drugs Market

The global Narcotic Opioid Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Narcotic Opioid Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Narcotic Opioid Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Narcotic Opioid Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Narcotic Opioid Drugs market.

Global Narcotic Opioid Drugs Scope and Market Size

Narcotic (Opioid) Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Narcotic (Opioid) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Codeine

Fentanyl

Hydrocodone

Hydromorphone

Meperidine

Methadone

Others

Segment by Application

Pain Relief Application

Anesthesia Application

By Company

Pfizer

Teva

Purdue Pharma

Mallinckrodt

Amneal Pharma

Collegium

Johnson & Johnson

Merck

Mylan

Hikma Pharmaceuticals

Sun Pharma

Endo Pharmaceuticals

Allergan

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Narcotic Opioid Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Narcotic Opioid Drugs, with price, sales, revenue, and global market share of Narcotic Opioid Drugs from 2019 to 2022.

Chapter 3, the Narcotic Opioid Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Narcotic Opioid Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Narcotic Opioid Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Narcotic Opioid Drugs.

Chapter 13, 14, and 15, to describe Narcotic Opioid Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Narcotic Opioid Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Narcotic (Opioid) Drugs Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 111 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Hydromorphone
1.2.6 Meperidine
1.2.7 Methadone
1.2.8 Others
1.3 Market by Application
1.3.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Relief Application
1.3.3 Anesthesia Application
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcotic (Opioid) Drugs Market Perspective (2017-2028)
2.2 Narcotic (Opioid) Drugs Growth Trends by Region
2.2.1 Narcotic (Opioid) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Narcotic (Opioid) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Narcotic (Opioid) Drugs Market Dynamics
2.3.1 Narcotic (Opioid) Drugs Industry Trends
2.3.2 Narcotic (Opioid) Drugs Market Drivers
2.3.3 Narcotic (Opioid) Drugs Market Challenges
2.3.4 Narcotic (Opioid) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue
3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2017-2022)
3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio
3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2021
3.5 Narcotic (Opioid) Drugs Key Players Head office and Area Served
3.6 Key Players Narcotic (Opioid) Drugs Product Solution and Service
3.7 Date of Enter into Narcotic (Opioid) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcotic (Opioid) Drugs Breakdown Data by Type
4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2023-2028)
5 Narcotic (Opioid) Drugs Breakdown Data by Application
5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Narcotic (Opioid) Drugs Market Size (2017-2028)
6.2 North America Narcotic (Opioid) Drugs Market Size by Type
6.2.1 North America Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
6.2.2 North America Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
6.2.3 North America Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
6.3 North America Narcotic (Opioid) Drugs Market Size by Application
6.3.1 North America Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
6.3.2 North America Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
6.3.3 North America Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
6.4 North America Narcotic (Opioid) Drugs Market Size by Country
6.4.1 North America Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
6.4.2 North America Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Narcotic (Opioid) Drugs Market Size (2017-2028)
7.2 Europe Narcotic (Opioid) Drugs Market Size by Type
7.2.1 Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
7.2.2 Europe Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
7.2.3 Europe Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
7.3 Europe Narcotic (Opioid) Drugs Market Size by Application
7.3.1 Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
7.3.2 Europe Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
7.3.3 Europe Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
7.4 Europe Narcotic (Opioid) Drugs Market Size by Country
7.4.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
7.4.2 Europe Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type
8.2.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application
8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
8.4.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Narcotic (Opioid) Drugs Market Size (2017-2028)
9.2 Latin America Narcotic (Opioid) Drugs Market Size by Type
9.2.1 Latin America Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
9.3 Latin America Narcotic (Opioid) Drugs Market Size by Application
9.3.1 Latin America Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country
9.4.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type
10.2.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application
10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
10.4.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Narcotic (Opioid) Drugs Introduction
11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Details
11.3.2 Purdue Pharma Business Overview
11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.3.5 Purdue Pharma Recent Developments
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Details
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.4.5 Mallinckrodt Recent Developments
11.5 Amneal Pharma
11.5.1 Amneal Pharma Company Details
11.5.2 Amneal Pharma Business Overview
11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.5.5 Amneal Pharma Recent Developments
11.6 Collegium
11.6.1 Collegium Company Details
11.6.2 Collegium Business Overview
11.6.3 Collegium Narcotic (Opioid) Drugs Introduction
11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.6.5 Collegium Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.7.5 Johnson & Johnson Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Narcotic (Opioid) Drugs Introduction
11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Narcotic (Opioid) Drugs Introduction
11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.9.5 Mylan Recent Developments
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Details
11.10.2 Hikma Pharmaceuticals Business Overview
11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.10.5 Hikma Pharmaceuticals Recent Developments
11.11 Sun Pharma
11.11.1 Sun Pharma Company Details
11.11.2 Sun Pharma Business Overview
11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.11.5 Sun Pharma Recent Developments
11.12 Endo Pharmaceuticals
11.12.1 Endo Pharmaceuticals Company Details
11.12.2 Endo Pharmaceuticals Business Overview
11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.12.5 Endo Pharmaceuticals Recent Developments
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Narcotic (Opioid) Drugs Introduction
11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
11.13.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Hydromorphone
Table 6. Key Players of Meperidine
Table 7. Key Players of Methadone
Table 8. Key Players of Others
Table 9. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Narcotic (Opioid) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Narcotic (Opioid) Drugs Market Share by Region (2017-2022)
Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Narcotic (Opioid) Drugs Market Share by Region (2023-2028)
Table 15. Narcotic (Opioid) Drugs Market Trends
Table 16. Narcotic (Opioid) Drugs Market Drivers
Table 17. Narcotic (Opioid) Drugs Market Challenges
Table 18. Narcotic (Opioid) Drugs Market Restraints
Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Narcotic (Opioid) Drugs Revenue Share by Players (2017-2022)
Table 21. Global Top Narcotic (Opioid) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021)
Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Narcotic (Opioid) Drugs Product Solution and Service
Table 26. Date of Enter into Narcotic (Opioid) Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2017-2022)
Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2023-2028)
Table 32. Global Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Narcotic (Opioid) Drugs Revenue Share by Application (2017-2022)
Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Narcotic (Opioid) Drugs Revenue Share by Application (2023-2028)
Table 36. North America Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Narcotic (Opioid) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Narcotic (Opioid) Drugs Product
Table 69. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 70. Pfizer Recent Developments
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Narcotic (Opioid) Drugs Product
Table 74. Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 75. Teva Recent Developments
Table 76. Purdue Pharma Company Details
Table 77. Purdue Pharma Business Overview
Table 78. Purdue Pharma Narcotic (Opioid) Drugs Product
Table 79. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 80. Purdue Pharma Recent Developments
Table 81. Mallinckrodt Company Details
Table 82. Mallinckrodt Business Overview
Table 83. Mallinckrodt Narcotic (Opioid) Drugs Product
Table 84. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 85. Mallinckrodt Recent Developments
Table 86. Amneal Pharma Company Details
Table 87. Amneal Pharma Business Overview
Table 88. Amneal Pharma Narcotic (Opioid) Drugs Product
Table 89. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 90. Amneal Pharma Recent Developments
Table 91. Collegium Company Details
Table 92. Collegium Business Overview
Table 93. Collegium Narcotic (Opioid) Drugs Product
Table 94. Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 95. Collegium Recent Developments
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Narcotic (Opioid) Drugs Product
Table 99. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 100. Johnson & Johnson Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Narcotic (Opioid) Drugs Product
Table 104. Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Mylan Company Details
Table 107. Mylan Business Overview
Table 108. Mylan Narcotic (Opioid) Drugs Product
Table 109. Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 110. Mylan Recent Developments
Table 111. Hikma Pharmaceuticals Company Details
Table 112. Hikma Pharmaceuticals Business Overview
Table 113. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 114. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 115. Hikma Pharmaceuticals Recent Developments
Table 116. Sun Pharma Company Details
Table 117. Sun Pharma Business Overview
Table 118. Sun Pharma Narcotic (Opioid) Drugs Product
Table 119. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 120. Sun Pharma Recent Developments
Table 121. Endo Pharmaceuticals Company Details
Table 122. Endo Pharmaceuticals Business Overview
Table 123. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 124. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 125. Endo Pharmaceuticals Recent Developments
Table 126. Allergan Company Details
Table 127. Allergan Business Overview
Table 128. Allergan Narcotic (Opioid) Drugs Product
Table 129. Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 130. Allergan Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcotic (Opioid) Drugs Market Share by Type: 2021 VS 2028
Figure 2. Codeine Features
Figure 3. Fentanyl Features
Figure 4. Hydrocodone Features
Figure 5. Hydromorphone Features
Figure 6. Meperidine Features
Figure 7. Methadone Features
Figure 8. Others Features
Figure 9. Global Narcotic (Opioid) Drugs Market Share by Application: 2021 VS 2028
Figure 10. Pain Relief Application Case Studies
Figure 11. Anesthesia Application Case Studies
Figure 12. Narcotic (Opioid) Drugs Report Years Considered
Figure 13. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Narcotic (Opioid) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Narcotic (Opioid) Drugs Market Share by Region: 2021 VS 2028
Figure 16. Global Narcotic (Opioid) Drugs Market Share by Players in 2021
Figure 17. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2021
Figure 19. North America Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 21. North America Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 22. North America Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 23. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 27. Europe Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 28. Europe Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 29. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Narcotic (Opioid) Drugs Market Size Share by Region (2017-2028)
Figure 39. China Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 49. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028)
Figure 55. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 59. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 60. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 61. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 62. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 63. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 64. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 65. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 66. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 67. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 68. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 69. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 70. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount